Gu Chunli, Du Hong, Li Ningying, Zhou Yunlong, Li Sha, Sun Yuchen, Han Yiyang, Xu Xuan, Li Xianrong
School of Nursing, Southwest Medical University, Luzhou, Sichuan, China.
Department of Orthopedics, The People's Hospital of Leshan, Leshan, Sichuan, China.
Front Endocrinol (Lausanne). 2025 Jul 16;16:1569152. doi: 10.3389/fendo.2025.1569152. eCollection 2025.
With the accelerated aging of the population, degenerative orthopedic diseases, particularly osteoporosis, have become a major public health challenge, threatening bone health and affecting the quality of life. Existing anti-osteoporosis regimens remain rather unitary or poorly adhered, which also limits the maintenance of bone health to some extent. Given the increasingly elucidated prominence of gut-related factors in osteoblasts/osteoclasts and bone formation/metabolism/maintenance, focusing on intestinal microecology and then targeting the distal bone tissue the gut-bone axis have been recognized as a feasible intervention strategy. This review systematically summarized the interaction of the gut-bone axis while highlighting the physicochemical barriers formed by intestinal intrinsic structures, the gut microbiota, and related molecules for bone health maintenance through the immune and endocrine pathways. Meanwhile, we emphasized the ideal anti-osteoporotic property and individual achievability of methods like fecal microbiota transplantation, probiotic and prebiotic supplementation, and dietary pattern modification. The conceptual framework of the gut-bone axis plus X was innovatively proposed, given the potential synergy among different organs in disease characterization and pathogenesis, which may help better explain the etiology and manage other co-morbidities concurrent with or secondary to osteoporosis. Since the intersection of orthopedics with other subjects, we also supported the application of nano-biomaterials, bacterial synthetic biology, and novel small molecules in anti-osteoporosis, which is expected to unlock broader prospects for the multidisciplinary integration of the gut-bone axis.
随着人口老龄化加速,退行性骨科疾病,尤其是骨质疏松症,已成为一项重大的公共卫生挑战,威胁骨骼健康并影响生活质量。现有的抗骨质疏松治疗方案仍然较为单一或依从性差,这在一定程度上也限制了骨骼健康的维持。鉴于肠道相关因素在成骨细胞/破骨细胞以及骨形成/代谢/维持中的作用日益明确,关注肠道微生态并进而靶向远端骨组织——肠-骨轴,已被认为是一种可行的干预策略。本综述系统总结了肠-骨轴的相互作用,同时强调了肠道固有结构、肠道微生物群以及相关分子通过免疫和内分泌途径形成的物理化学屏障对维持骨骼健康的作用。与此同时,我们强调了粪便微生物群移植、补充益生菌和益生元以及改变饮食模式等方法在抗骨质疏松方面的理想特性和个体可实现性。鉴于不同器官在疾病特征和发病机制中可能存在协同作用,创新性地提出了肠-骨轴加X的概念框架,这可能有助于更好地解释病因并管理与骨质疏松症并发或继发的其他合并症。由于骨科与其他学科的交叉,我们还支持纳米生物材料、细菌合成生物学和新型小分子在抗骨质疏松中的应用,有望为肠-骨轴的多学科整合开辟更广阔的前景。